ARE — what changed in the latest 10-Q

Text added vs the prior filing · source: 10-Q · 2026-08-03

• (As of or for the three months ended June 30, 2026, unless stated otherwise)

• Occupancy of operating properties, including executed leases with future occupancy

• Rents and receivables for the three months ended June 30, 2026, collected as of the date of this report

• •Significant liquidity of $3.60 billion and extension of our $5.0 billion unsecured senior line of credit to 2032.

• •9.7-year weighted-average remaining debt term, the longest among S&P 500 REITs.

Text removed vs the prior filing · source: 10-Q · 2026-04-27

• Net income (loss) attributable to Alexandria’s common stockholders – diluted:

• Funds from operations attributable to Alexandria’s common stockholders – diluted, as

• Adjusted EBITDA margin for the three months ended March 31, 2026

• Rents and receivables for the three months ended March 31, 2026, collected as of the date of this report

• •Our credit ratings from S&P Global Ratings and Moody’s Ratings were BBB+ and Baa1, respectively, which rank in the top

Text removed vs the prior filing · source: 10-Q · 2026-04-27

• fixed- and variable-rate debt as of March 31, 2026 (in thousands):

Text added vs the prior filing · source: 10-Q · 2026-08-03

• United States District Court for the Central District of California. The operative complaint alleges violations of the federal securities laws

• based on alleged material misrepresentations and omissions related to the Company’s business performance and real estate

• impairment charges. The complaint seeks damages and other relief on behalf of investors who acquired the Company’s securities

• between January 30, 2024 and December 5, 2025. The defendants moved to dismiss the action on May 20, 2026.

• On February 3, 2026, March 25, 2026, and June 25, 2026, stockholder derivative actions were filed against certain officers and

Text removed vs the prior filing · source: 10-Q · 2026-04-27

• United States District Court for the Central District of California. On April 15, 2026, the lead plaintiffs filed an amended complaint

• alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder, based on alleged

• material misrepresentations and omissions related to the Company’s business performance and real estate impairment charges

• (captioned Hern v. Alexandria Real Estate Equities, Inc., et al.). The amended complaint seeks damages and other relief on behalf of

• investors who acquired the Company’s securities between January 30, 2024 and December 5, 2025. The Company does not believe

Text added vs the prior filing · source: 10-Q · 2026-08-03

• On June 17, 2026, Marc E. Binda, our Chief Financial Officer and Treasurer, terminated a Rule 10b5-1 trading arrangement

• that he had previously adopted in December 2025 for the sale from time to time of up to 23,368 shares of common stock. The trading

• arrangement was intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c) and was scheduled

• On June 18, 2026, Hallie E. Kuhn, our Executive Vice President – Capital Markets and Co-Lead – Life Science, terminated a

• Rule 10b5-1 trading arrangement that she had previously adopted in December 2025 for the sale from time to time of up to 2,574

Text removed vs the prior filing · source: 10-Q · 2026-04-27

• During the three months ended March 31, 2026, none of our officers or directors adopted or terminated any contract,

• instruction, or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of

• Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement.”